VR Logo

SI-BONE Inc. (SIBN) download report


Healthcare | Medical Devices & Equipment

SI-BONE Inc. (SIBN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

IPO Date: 17-Oct-2018

CEO & Director: Ms. Laura A. Francis MBA

Chief Financial Officer: Mr. Anshul Maheshwari

Listing: NASDAQ: SIBN

Country: United States

Headquarters: Santa Clara, CA

Website: https://si-bone.com

Key Facts

Market cap: $461.22 Mln

Revenue (TTM): $92.15 Mln

Earnings (TTM): $-61.74 Mln

Cash: $130.73 Mln

Total Debt: $40.20 Mln

Insider's Holding: 1.69%

Liquidity: Low

52 Week range: $11.89 - 32.13

Shares outstanding: 33,913,000

8 Years Aggregate:

  • CFO: $-203.67 Mln
  • EBITDA: $-162.24 Mln
  • Net Profit: $-255.71 Mln

Stock Performance

Time Period SI-BONE (SIBN) S&P BSE Sensex* S&P Small-Cap 600*
YTD-38.77-8.62-18.78
1 month-5.36-4.54-8.00
3 months-39.82-10.19-13.65
1 Year-56.781.43-17.19
3 Years-12.5610.146.10
5 Years--11.265.87
10 Years--11.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year SI-BONE (SIBN) S&P Small-Cap 600 S&P BSE Sensex
2021-25.7225.2721.99
202039.079.5715.75
20192.9220.8614.38